Advertisement
Screener

PASSAGE BIO, INC. (PASG) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

PASSAGE BIO, INC. Cash Flow Breakdown

Cash flow breakdown shows where PASSAGE BIO, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $31.51M went out.
  • Fiscal year ended 2025-12-31: from investing, $40.22M came in.
  • Fiscal year ended 2025-12-31: from financing, $23.00K came in.
  • Fiscal year ended 2025-12-31: change in cash, $8.73M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$31.51M$40.22M$23.00K$8.73M
2024-12-31-$47.96M$54.95M$35.00K$8.84M*$15.86M
2023-12-31-$78.26M$65.24M$135.00K-$12.89M
2022-12-31-$118.21M$25.20M$129.00K-$1.48M*-$94.36M
2021-12-31-$126.88M-$45.81M$165.81M$850.00K*-$6.04M
2020-12-31-$80.52M-$172.11M$228.26M-$23.87M
2019-12-31-$39.90M-$1.69M$176.00K$175.43M*$134.01M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$9.18M*$0.00*
2026-03-31-$12.99M$20.00K-$12.97M
2025-12-31-$6.48M*$0.00*$9.00K*
2025-09-30-$4.85M*$0.00*$0.00*
2025-06-30-$6.33M*$585.00K*
2025-03-31-$13.85M$39.63M$25.78M
2024-12-31-$8.44M*$13.68M*$0.00*
2024-09-30-$7.45M*$14.97M*$0.00*
2024-06-30-$13.14M*$1.05M*
2024-03-31-$18.93M$25.25M$8.74M*$15.06M
2023-12-31-$19.52M*$7.60M*$46.00K*
2023-09-30-$19.16M*$22.45M*$0.00*
2023-06-30-$17.14M*$13.97M*
2023-03-31-$22.45M$21.22M-$1.23M
2022-12-31-$24.02M*-$3.36M*$1.00K*-$589.00K*
2022-09-30-$23.39M*-$4.76M*$79.00K*
2022-06-30-$26.08M*$16.00M*$0.00*
2022-03-31-$44.71M$17.31M$49.00K-$27.35M
2021-12-31-$30.77M*-$3.60M*$1.00K*
2021-09-30-$41.06M*-$11.55M*$0.00*
2021-06-30-$24.33M*-$10.26M*$0.00*$523.00K*
2021-03-31-$30.72M-$20.40M$165.81M$114.52M
2020-12-31-$29.42M*-$36.55M*$0.00*
2020-09-30-$17.53M*-$135.37M*$0.00*
2020-06-30-$11.71M*-$94.00K*-$1.64M*
2020-03-31-$21.85M-$99.00K$229.90M$207.95M
2019-12-31-$17.48M*-$43.00K*$0.00*-$799.00K*
2019-09-30-$11.42M*-$109.00K*$0.00*$109.94M*
2019-06-30-$10.78M*-$657.00K*$0.00*$46.31M*
2019-03-31-$214.00K-$884.00K$176.00K$19.98M*$19.06M

Similar stocks

Stock NameCountryMarket CapPE Ratio
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
IN8BIO, INC. (INAB)United States$0.012B-0.76
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23